Home / Products / Pharmacopoeial impurities / Cefuroxime sodium GSK ring opening impurity

Cefuroxime sodium GSK ring opening impurity

CAS Cat. no. RA-C013001 On synthesis

A pharmacopoeial impurity reference standard for this drug substance, characterised by HPLC, mass spectrometry and 1H NMR, and released with a lot-specific certificate of analysis.

Molecular formulaC15H18N4O7S
Molecular weight398.39 g/mol
Available packs5 mg, 10 mg, 25 mg
DocumentationCOA · SDS · spec sheet
StorageSee certificate

No price is published: pack size, documents and shipping are confirmed in one quotation.

Chemical structure of Cefuroxime sodium GSK ring opening impurity, CAS

What this record covers

Cefuroxime sodium GSK ring opening impurity (CAS ) is supplied as a pure organic reference material under ISO 17034:2016 (ANAB, AR-2832). Each lot is weighed, dispensed and released against a specification that includes identity by mass spectrometry and 1H NMR, and purity by HPLC.

Typical use

Related-substance method development and validation, identification of impurity peaks in this drug substance drug substance, system suitability, and quantitative calibration where a defined reference is required.

Shipping and storage

Shipped worldwide with the SDS and, where applicable, a non-hazardous declaration. Cold-chain and dry ice are used when the material requires it; the storage condition and retest date are stated on the lot certificate rather than assumed from the catalogue.

Identifiers: catalogue RA-C013001 · CAS · formula C15H18N4O7S · MW 398.39. If you need a different pack size or a co-lot certificate, ask — both are routine.

Other standards for this drug substance